Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

265

P687 Disproportionate Impairment in Diffusing Capacity Is a Predictor of Pulmonary Vascular Resistance in Chronic Obstructive Pulmonary Disease/ A. Balasubramanian, Baltimore, MD P688 Sub-Maximal Exercise Testing in Interstitial Lung Disease: Assessing the Role of GXCAP to Detect Concomitant Pulmonary Hypertension/ N. Moallem, Farmington, CT P689 Utility of Pulmonary Function Testing in Detection of Pulmonary Hypertension in COPD/ M. Sameed, Cleveland, OH P690 Increased Risk of Post-liver Transplant Pulmonary Complications in Patients With Abnormal Non-invasive Hemodynamics, Even Without Significant Pulmonary Hypertension/ A.C. Osuji, Chicago, IL Responses to General Anesthesia and Perioperative Outcomes in Congenital Heart Disease Associated Pulmonary Arterial Hypertension/ H. Zhang, Beijing, China P693 Characteristics of Exercise Intolerance in Different Subgroups of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease/ H. Zhang, Beijing, China P694 Variabilityin the Calculation of Pulmonary Vascular Resistance in Patients With Idiopathic Pulmonary Fibrosis/ O.J. Cantres, Fairfax, VA P691 Characteristics of WHO Group 3 Pulmonary Hypertension Patients With Positive Vasoreactivity: Data From a Single Center/ C. Tanba, Baltimore, MD P692 Association Between Pulmonary Hemodynamic

P698 Impact of Pulmonary Hypertension on In-hospital Outcomes and Healthcare Utilizations Among Patient Admitted With COVID-19 Infection in 2020/ N.A.N. Patel, Valenzuela, Philippines P699 Pulmonary Hemorrhage in COVID-19: A Systematic Review/ I. Ogbuka, Knoxville, TN P700 Pulmonary Vascular Effects of a Personalized Rehab Program in Patients With Post-Acute Sequelae of COVID-19 (PASC)/ W. Dierckx, Kontich, Belgium P701 Complement Activation in Lung Endothelial Cells Contributes to Endothelial Inflammation Induced by SARS-CoV-2 in Hypoxia/ H. Zhang, Aurora, CO P702 Echocardiographic Findings in Patients With COVID-19-related Venous Thromboembolism/ A. Jones, Miami, FL P703 Right Ventricular Systolic Pressure in Coronavirus Disease 2019 (COVID-19) Patients/ A.A. Vazquez-Suarez, Heroica Matamoros, Mexico P704 Characteristics of Patients With Post-COVID-19 Pulmonary Embolism/ B.A. Milenkovic, Belgrade, Serbia P705 Post-COVID-19 Patients Show Vascular Sequelae That Last Up to 6 Months/ P. Poyatos, Salt, Girona, Spain P706 Influence of the Day of Admission on Mortality and Other Outcomes Among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With Acute Pulmonary Embolism: A Nationwide Analysis/ B.A. Casipit, Philadelphia, PA P707 The Value of D-dimer Elevation for Prediction of

Pulmonary Embolism in Patients With Baseline Elevation Due to COVID-19/ S. Treat, Knoxville, TN

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION EXPANDING THE VENN DIAGRAM: COVID-19 AND THE PULMONARY VASCULATURE

CLINICAL THEMATIC POSTER SESSION

C64

C65

A LOT OF FUNGI!

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area G, Hall C (Lower Level)

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area C, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P696 Transcriptomic Signature of Acute VTE Associated With SARS-CoV-2 Infection; Single Center Retrospective Observational Study/ S.B. Brosnahan, New York, NY

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P249 Case Of Disseminated Blastomycosis With Laryngeal Involvement/ P. Shelley, Louisville, KY P250 Disseminated Mucormycosis in a Non-neutropenic Patient: An Autopsy Case Report/ C. Perez, Akron, OH P251 A Case of Severe Invasive Pulmonary Aspergillosis in COVID-19 Patient/ S. Khan, Joplin, MO

P697 Role of Toll-like Receptor 3 Deficiency in the

Pathobiology of SARS-CoV-2 Associated Lung Vascular Remodeling/ L. Farkas, Columbus, OH

ATS 2023 • Washington, DC